On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdaySep 21, 2017 12:59 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 21, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DGJI 26.13% – News: Begins trading on the OTCQX® Best Market NVFY 17.66% – News: Diamond Sofa named as one of the top five Asian American Brands by US News Express MRIC 13.18% – News: Presenting at the 2017 MicroCap Conference on October 5 LTEA 9.95% – News: Becomes the official Iced Tea of Barclays Center IZEA 8.57% – News: Launches first Augmented Sponsorship™ campaign LPCN 5.00% – News: Reports positive motions decision by…

Continue Reading

ThursdaySep 21, 2017 11:52 am

NetworkNewsBreaks – Tantech Holdings Ltd.’s (NASDAQ: TANH) Subsidiary Secures $20M Electric Vehicle Order

Tantech Holdings (NASDAQ: TANH) this morning said that its 70% owned subsidiary, Suzhou E Motors Buses Co., Ltd., has signed sales contracts for its electric vans and buses worth approximately $20 million. Per the contracts, Zhenjiang Baichuan New Energy Automobile Co., Ltd. intends to purchase 450 all-electric vans and 10 all-electric buses from Tantech with a projected unit sales price of U.S. $43,077. In addition to the unit sales price, Tantech may be eligible to receive Chinese government subsidies for electric car sales. Tantech is expecting to deliver the order by the end of 2017. "In addition to manufacturing a…

Continue Reading

ThursdaySep 21, 2017 11:50 am

NetworkNewsBreaks – Onconova Therapeutics, Inc. (NASDAQ: ONTX) Enters Strategic Collaboration with Cellectar Biosciences, Inc. (NASDAQ: CLRB) to Develop New PDCs

Shares of Onconova Therapeutics (NASDAQ: ONTX) are up 6% after the company this morning said it has entered into a strategic collaboration with Cellectar Biosciences (NASDAQ: CLRB) to develop new phospholipid drug conjugates (PDCs). The companies intend to combine Cellectar’s patented phospholipid ether delivery platform with select proprietary compounds or payloads from Onconova’s early stage product pipeline. Per the terms of the collaboration, Onconova will provide several compounds to Cellectar, which will then link to its PDC platform to create new, more precisely targeted antitumor agents. “We are focused on optimizing the delivery of our therapeutic compounds in the battle…

Continue Reading

ThursdaySep 21, 2017 11:45 am

NetworkNewsBreaks – 92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) Acquires Three New Lithium Properties in Quebec

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) today announced the acquisition of three highly prospective hard-rock lithium properties in the James Bay region of Quebec, Canada. The properties, consisting of a combined 115 mineral claims on approximately 14,710 acres, complement the company’s asset portfolio of lithium-bearing spodumene-bearing pegmatite resources. “As we continue to aggressively advance our flagship Hidden Lake Lithium Project in NWT (Northwest Territories), we feel it is critical to maintain a pipeline of additional high-quality, early-staged, lithium pegmatite projects, each with potential as stand-alone opportunities,” Adrian Lamoureux, CEO of 92 Resources, said in a news release.…

Continue Reading

ThursdaySep 21, 2017 11:42 am

NetworkNewsBreaks – Jim Stearns Takes on Role of Senior Managing Director at RHK Capital

RHK Capital recently announced the addition of Jim Stearns to its investment banking and capital markets team as Senior Managing Director. Stearns, who comes to RHK Capital with over 42 years of investment banking and advisory experience, has spent the last 23 years as a Managing Director and Partner of Roth Capital Partners, LLC. Stearns first initiated and managed the firm’s corporate finance activities in the Pacific Northwest and later its national Industrial’s Group. Among Stearns accomplishments are initiating and leading the firm’s domestic and international OTCQX initiatives and executing a wide variety of transactions including M&A advisory, initial public…

Continue Reading

ThursdaySep 21, 2017 9:19 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Inclusion in CSE25 Index

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has been included in the CSE25 Index after qualifying as one of the 25 largest companies in the CSE Composite Index. Per the update, the CSE25 Index is a subgroup of the CSE Composite Index, which was launched in 2015 and currently includes nearly half of the exchange’s listed companies and over 75 percent of the trading activity on the Canadian Securities Exchange. The CSE25 Index includes the top 25 securities contained within the CSE Composite Index based on market capitalization. According to the…

Continue Reading

WednesdaySep 20, 2017 2:37 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 20, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DMPI 87.60% – News: Receives U.S. patent regarding VAL-083 KPAY 23.02% – News: Reports record growth PPCB 17.39% – News: Provides shareholder update regarding PRP DRNA 14.78% – News: Participating in the LEERINK Partners Roundtable Series: Rare Disease and Immuno-Oncology on September 27 ISCO 12.42% – News: Advances toward phase 2 clinical trial in traumatic brain injury program ALT 7.92% – News: Receives FDA clearance to initiate phase 2 clinical study of NasoVAX SSC…

Continue Reading

WednesdaySep 20, 2017 2:37 pm

NetworkNewsBreaks – ROTH Capital Partners Names New Members of Healthcare Research Team

ROTH Capital Partners, a full service investment bank focused on serving emerging growth companies and their investors, this morning said that Jotin Marango, M.D., Ph.D. and Yasmeen Rahimi, Ph.D. have joined the firm’s healthcare research team. Dr. Marango joins ROTH from H.C. Wainwright & Co., where he covered hematology, oncology, and pulmonary therapeutics, with a specific focus on epigenetic and molecularly targeted therapies. Dr. Rahimi also joins ROTH from H.C. Wainwright & Co. Prior to her time at H.C. Wainwright & Co., she was a research associate at Guggenheim Securities. “Coupled with the recent additions to our healthcare banking team,…

Continue Reading

WednesdaySep 20, 2017 2:37 pm

NetworkNewsBreaks – HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) Strengthens IP Portfolio with Two New Method Patents Covering Technology

Shares of HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) are up 13% after the company this morning said it has been issued two new U.S. patents by the United States Patent and Trademark Office covering the company’s technology and applications of its technology. The first patent, entitled Molecular Malignancy in Melanocytic Lesions (U.S. Patent 9,758,829), was issued to HTG and the John Wayne Cancer Institute, who co-invented the technology. The patent claims a method of treatment on an indeterminate or atypical nevi that involves measuring the nucleic acid expression of certain biomarkers, including MAGEA2, PRAME, PDIA4, NR4A1, PDLIM7, B4GALT1, SAT1, RUNX1,…

Continue Reading

WednesdaySep 20, 2017 11:15 am

NetworkNewsBreaks – Terra Tech Corp. (TRTC) Signs Second Craft Cultivator to Grow Proprietary Cannabis Brand

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, recently announced a new farm partnership with a second Craft Cultivator to grow the company’s proprietary high grade “IVXX” cannabis flowers and oils. The farm, Cultivar Inc., located in Salinas, California, is approved for up to six acres (approximately 244,000 square feet) of cannabis cultivation in high tech, climate-controlled greenhouses. “We selected Cultivar to be our newest Cannabis Craftsman as it uses an all-natural cultivation methodology that upholds the high standards associated with our proprietary IVXX brand, including sustainable farming practices and the production of pesticide-free cannabis products,” Derek…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217